Linden Advisors’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.3K Hold
435,179
– – ﹤0.01% 612
2026
Q1
$45.7K Hold
435,179
– – ﹤0.01% 512
2025
Q4
$24.2K Hold
435,179
– – ﹤0.01% 448
2025
Q3
$31.6K Hold
435,179
– – ﹤0.01% 382
2025
Q2
$35.9K Hold
435,179
– – ﹤0.01% 347
2025
Q1
$39.1K Buy
435,179
+185,179
+74% +$19.2K ﹤0.01% 269
2024
Q4
$61.4K Buy
+250,000
New +$9.9K ﹤0.01% 212

Other funds holding BDMDW

Linden Advisors's BDMDW Position: Q2 2026 in Review

Linden Advisors held its Baird Medical Investment Holdings Warrant (BDMDW) position steady in Q2 2026 at 435,179 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #612.

Linden Advisors first reported a position in BDMDW in Q4 2024 and has held it in 7 quarters since. The position peaked at $61.4K in Q4 2024. 29 funds tracked by Wall St. Rank hold BDMDW as of Q2 2026.

  • Linden Advisors held 435,179 shares of Baird Medical Investment Holdings Warrant worth $21.3K as of Q2 2026.
  • Linden Advisors left its Baird Medical Investment Holdings Warrant share count unchanged in Q2 2026.
  • Baird Medical Investment Holdings Warrant made up ﹤0.01% of Linden Advisors's portfolio in Q2 2026, its #612 holding.
  • Linden Advisors first reported a position in Baird Medical Investment Holdings Warrant in Q4 2024 and has held it in 7 quarters since.
  • Linden Advisors's Baird Medical Investment Holdings Warrant position peaked at $61.4K in Q4 2024.
  • 29 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q2 2026.

Based on Linden Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.